235 related articles for article (PubMed ID: 26931394)
21. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis.
Boonk SE; Çetinözman F; Vermeer MH; Jansen PM; Willemze R
J Cutan Pathol; 2015 Sep; 42(9):604-9. PubMed ID: 25777533
[TBL] [Abstract][Full Text] [Related]
23. TOX expression in cutaneous B-cell lymphomas.
Schrader AM; Jansen PM; Willemze R
Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
[TBL] [Abstract][Full Text] [Related]
24. Thymocyte selection-associated high-mobility group box as a potential diagnostic marker differentiating hypopigmented mycosis fungoides from early vitiligo: A pilot study.
Ibrahim MA; Mohamed A; Soltan MY
Indian J Dermatol Venereol Leprol; 2021; 87(6):819-825. PubMed ID: 31857520
[TBL] [Abstract][Full Text] [Related]
25. Loss of 5-Hydroxymethylcytosine Is an Epigenetic Biomarker in Cutaneous T-Cell Lymphoma.
Qiu L; Liu F; Yi S; Li X; Liu X; Xiao C; Lian CG; Tu P; Wang Y
J Invest Dermatol; 2018 Nov; 138(11):2388-2397. PubMed ID: 29803640
[TBL] [Abstract][Full Text] [Related]
26. Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma.
Litvinov IV; Netchiporouk E; Cordeiro B; Zargham H; Pehr K; Gilbert M; Zhou Y; Moreau L; Woetmann A; Ødum N; Kupper TS; Sasseville D
Oncoimmunology; 2014 Nov; 3(11):e970025. PubMed ID: 25941598
[TBL] [Abstract][Full Text] [Related]
27. Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas.
Nikolova M; Bagot M; Boumsell L; Bensussan A
Leuk Lymphoma; 2002 Apr; 43(4):741-6. PubMed ID: 12153159
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
Parker SR; Bethaney JV
G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
[TBL] [Abstract][Full Text] [Related]
29. The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort.
Dobos G; De Cevins C; Ly Ka So S; Jean-Louis F; Mathieu S; Ram-Wolff C; Resche-Rigon M; Bensussan A; Bagot M; Michel L
Br J Dermatol; 2021 Aug; 185(2):405-411. PubMed ID: 33314029
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
[TBL] [Abstract][Full Text] [Related]
31. Erythrodermic CD4/CD8 Double-Negative Mycosis Fungoides: A Case Report.
Alnasser MA; AlKhawajah NM; AlQadri NG; Shadid AM; Alsaif FM
Case Rep Oncol; 2021; 14(1):256-261. PubMed ID: 33776713
[TBL] [Abstract][Full Text] [Related]
32. Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker.
Roelens M; de Masson A; Ram-Wolff C; Maki G; Cayuela JM; Marie-Cardine A; Bensussan A; Toubert A; Bagot M; Moins-Teisserenc H
Br J Dermatol; 2020 Jun; 182(6):1415-1422. PubMed ID: 31487384
[TBL] [Abstract][Full Text] [Related]
33. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
Wong HK
G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
[TBL] [Abstract][Full Text] [Related]
34. The relevance of morphometry in the differential diagnosis of cutaneous T cell lymphomas.
van der Loo EM; van Vloten WA; Cornelisse CJ; Scheffer E; Meijer CJ
Br J Dermatol; 1981 Mar; 104(3):257-69. PubMed ID: 6971118
[TBL] [Abstract][Full Text] [Related]
35. Sezary syndrome: cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificity.
Balfour EM; Glusac EJ; Heald P; Talley LL; Smoller BR
J Cutan Pathol; 2003 Aug; 30(7):437-42. PubMed ID: 12859741
[TBL] [Abstract][Full Text] [Related]
36. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
37. Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications.
Hsi AC; Lee SJ; Rosman IS; Carson KR; Kelley A; Viele V; Pang X; Musiek A; Schaffer A
J Am Acad Dermatol; 2015 Jan; 72(1):159-67. PubMed ID: 25440432
[TBL] [Abstract][Full Text] [Related]
38. Isolation of a CD8alphaalpha+ CD4- tumour T-cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T-cell lymphoma.
Nikolova M; Echchakir H; Wechsler J; Boumsell L; Bensussan A; Bagot M
Br J Dermatol; 2003 Jan; 148(1):24-9. PubMed ID: 12534590
[TBL] [Abstract][Full Text] [Related]
39. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
[TBL] [Abstract][Full Text] [Related]
40. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]